REGISTER for the upcoming webinar: Contemporary Management of Central Sleep Apnoea (CSA), on 5 March 2024, 14:00 – 15:30 CET.
Sleep-disordered breathing is characterized by the presence of both obstructive and central events. Common pathophysiologic mechanisms may produce mixed or blended sleep breathing disorders. Yet, ‘pure’ forms of both may dominate the clinical picture. Patients who predominantly present with central sleep apnoea (CSA) are often difficult to treat. The efficacy of conventional treatments such as medications, oxygen administration and positive airway pressure (PAP) therapy may be unsatisfactory. In recent years, phrenic stimulation has been introduced as a safe and viable treatment alternative for selected CSA patients. In the current webinar, expert opinion will be presented on the rationale of CSA treatment and on the do’s and don’ts of the different treatment options.
This webinar will be moderated by ESRS Vice President (Clinical) Prof. Dr. Dirk Pevernagie. He will be joined by several panellists who will address the following topics:
This webinar is sponsored by Zoll Respicardia. The views expressed by speakers or other third parties in ESRS webinars, events and/or conferences are those of the speaker or third-party and not necessarily of ESRS.